trending Market Intelligence /marketintelligence/en/news-insights/trending/c991gqkz9fee8t4sskh4pg2 content
BY CONTINUING TO USE THIS SITE, YOU ARE AGREEING TO OUR USE OF COOKIES. REVIEW OUR
PRIVACY & COOKIE NOTICE
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *

* Required

In this list

Antibe Therapeutics completes private placement, raises C$2.7M

Street Talk Episode 41 - How to Win the Funding Battle, Use Fintech to Play Offense

Forward Spark Spreads Suggest Rising Profitability Of US Renewables As Sector Matures

MA Activity The Big Story In Mature Online Video Platform Market

Martina Cheung Backs The Quality Program


Antibe Therapeutics completes private placement, raises C$2.7M

Antibe Therapeutics Inc. completed the second and final closing of its private placement, raising another C$297,750 in gross proceeds to bolster the C$2.4 million raised in the first tranche of the offering.

The net proceeds of approximately C$2.7 million will be used for clinical development and general purposes.

The issued securities are subject to a four-month statutory hold period and a TSX Venture Exchange hold period, each expiring April 22, 2017.